This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Bio-Flurazepam (December 21, 2012)

Starting date:
December 21, 2012
Posting date:
December 21, 2012
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-16883

Recalled Products

A. Bio-Flurazepam (December 21, 2012)

Reason

Lot 456321 of the product Bio-Flurazepam was recalled since the available stability data do not support the product shelf life of 24 months.

Depth of distribution

Wholesalers and pharmacies in Canada.

Affected products

A. Bio-Flurazepam (December 21, 2012)

DIN, NPN, DIN-HIM
DIN 022481274
Dosage form

Capsule

Strength

30 mg / capsule

Lot or serial number

Lot 456321

Companies
Recalling Firm
BioMed 2002 Inc. 5950 Cote de Liesse, Suite 100 Mont-Royal, Quebec H4T 1E3
Marketing Authorization Holder
BioMed 2002 Inc. 5950 Cote de Liesse, Suite 100 Mont-Royal, Quebec H4T 1E3

Date modified: